SEC Form 4 · accession 0001209191-18-048554

Bionano Genomics, Inc. · BNGO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Scientific Officer

Period of report

Aug 23, 2018

Accepted (ET)

Aug 27, 2018 · 6:48 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001411690

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Aug 23, 2018	C	5,941	—	A	7,354	D
Common Stock^F1	Aug 23, 2018	C	1,231	—	A	8,585	D
Common Stock^F1	Aug 23, 2018	C	101,918	—	A	110,503	D
Common Stock^F1	Aug 23, 2018	C	2,433	—	A	112,936	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series B Convertible Preferred Stock^F1	—	Aug 23, 2018	C	254,275	D	—	—	Common Stock	5,941	D
Series C Convertible Preferred Stock^F1	—	Aug 23, 2018	C	52,720	D	—	—	Common Stock	1,231	D
Series D Convertible Preferred Stock^F1	—	Aug 23, 2018	C	4,362,062	D	—	—	Common Stock	101,918	D
Series D-1 Convertible Preferred Stock^F1	—	Aug 23, 2018	C	104,167	D	—	—	Common Stock	2,433	D

F1Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date.